Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate.

Autor: Sung JC; Research Department, DreamTec Cytokines Limited, Hong Kong, China.; Oristry BioTech (HK) Limited, Hong Kong, China.; Meserna Therapeutic (HK) Limited, Hong Kong, China.; L&L Immunotherapy Company Limited, Hong Kong, China., Liu Y; Research Department, DreamTec Cytokines Limited, Hong Kong, China.; Meserna Therapeutic (HK) Limited, Hong Kong, China., Wu KC; Research Department, DreamTec Cytokines Limited, Hong Kong, China., Choi MC; Research Department, DreamTec Cytokines Limited, Hong Kong, China., Ma CH; Research Department, DreamTec Cytokines Limited, Hong Kong, China., Lin J; Research Department, DreamTec Cytokines Limited, Hong Kong, China.; L&L Immunotherapy Company Limited, Hong Kong, China., He EIC; Research Department, DreamTec Cytokines Limited, Hong Kong, China., Leung DY; Zentrogene Bioscience Laboratory Limited, Hong Kong, China.; Health Plus Laboratory Limited, Hong Kong, China., Sze ET; School of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China., Hamied YK; Cipla Limited, Mumbai 400013, India., Lam DM; L&L Immunotherapy Company Limited, Hong Kong, China.; Torsten Wiesel International Research Institute, Sichuan University, Chengdu 610017, China., Kwong KW; Research Department, DreamTec Cytokines Limited, Hong Kong, China.; Oristry BioTech (HK) Limited, Hong Kong, China.; Meserna Therapeutic (HK) Limited, Hong Kong, China.; Cipla Limited, Mumbai 400013, India.

Publikováno v: Vaccines [Vaccines (Basel)] 2021 Dec 21; Vol. 10 (1). Date of Electronic Publication: 2021 Dec 21.